Secondary acute myeloid leukemia early after therapy for Hodgkin's disease--a case report
Mihailov, G.; Ganeva, P.; Vassileva, N.; Guenova, M.; Balacenko, G.; Toshkov, S.; Hodjadjik, D.
Journal of BUON Official Journal of the Balkan Union of Oncology 12(3): 403-406
2007
ISSN/ISBN: 1107-0625 PMID: 17918297 Document Number: 614605
A case of acute myeloid leukemia (AML) after successful therapy for Hodgkin's disease (HD) is reported. The patient was diagnosed with stage IIB HD at the age of 25. She was treated with chemotherapy and radiotherapy (RT), and complete remission (CR) was achieved. Seven months after the CR was obtained the patient developed AML. Knowing that the prognosis of patients with secondary AML (sAML) after primary HD is poor we decided to perform autologous peripheral stem cells' transplantation.
Document emailed within 1 workday
Related Documents
Carneiro, P.C.; Pereira, E.D.; Mitteldorf, C.S.; Martinez, G.A.; Beitler, B.; Pozzi, D.H. 1989: Acute myeloid leukemia after treatment of Hodgkin's disease Revista do Hospital das Clinicas 44(2): 87-90Ishikawa, M.; Nakayama, K.; Rahman, M.T.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Iida, K.; Nakayama, N.; Miyazaki, K. 2014: Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report European Journal of Gynaecological Oncology 35(4): 443-448
Rossetti, F.; Messina, C.; Colleselli, P.; De Silvestro, G.; Sotti, G.; Destro, R.; Zanesco, L. 1991: Autologous bone marrow transplantation in secondary acute monoblastic leukemia following Hodgkin's disease Bone Marrow Transplantation 7(Suppl 3): 131-132
Zinzani, P.L.; Fiacchini, M.; Mazza, P.; Gherlinzoni, F.; Bocchia, M.; Tura, S. 1991: Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia Haematologica 76(4): 305-310
Liu, J.; Guo, R.; Jiang, Z.X. 2017: Cladribine in the treatment of TET 2(+) refractory acute myeloid leukemia: a case report Zhonghua Nei Ke Za Zhi 56(10): 769-770
Zaccaria, A.; Baccarani, M.; Lauria, F.; Fiacchini, M.; Mazza, P.; Tura, S. 1979: Acute leukemia in patients treated for Hodgkin's disease: report of two cases Haematologica 64(4): 455-462
Ysebaert, L.; Carli, P.M.; Casasnovas, R.O.; Girodon, F.; Caillot, D.; Mugneret, F.; Maynadié, M. 2001: Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report Leukemia 15(10): 1673-1674
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Morales, E.; Bancalari, G.; Fahrenkrog, A.M.; Rossle, A. 1999: Chronic myeloid leukemia and non Hodgkin lymphoma in the same patient. Clinical case Revista Medica de Chile 127(9): 1105-1107
Dallegri, F.; Mela, G.S.; Patrone, F.; Parodi, M. 1977: Granulocyte acid phosphatase activity during the course of chronic myeloid leukemia and Hodgkin's disease Bollettino della Societa Italiana di Biologia Sperimentale 53(1-2): 50-53
Mele, A.; Sparaventi, G.; Guiducci, B.; Nicolini, G.; d'Adamo, F.; Leopardi, G.; Delfini, C.; Piccaluga, P.; Visani, G. 2004: Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report Haematologica 89(6 Suppl): Ecr18
Centurioni, R.; Brianzoni, F.; Leoni, P.; Danieli, G. 1993: Hodgkin's disease, splenectomy and secondary leukemia Haematologica 78(4): 258-259
Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Sciarra, A.; Perrotti, A.; Zaccari, G.; Papa, G. 1993: Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Thrombosis and Haemostasis 70(4): 568-572
Sciarra, A.; Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Olivieri, M.; Perrotti, A.; Zaccari, G.; Amadori, S.; Papa, G. 1995: Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma Recenti Progressi in Medicina 86(2): 57-62
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Hoppe, R.T. 1992: Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease Leukemia 6(Suppl 4): 155-157
Mitarnun, W.; Pradutkanchana, J.; Takao, S.; Saechan, V.; Suwiwat, S.; Ishida, T. 2002: Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis Journal of the Medical Association of Thailand 85(5): 552-559
Mejía-Aranguré, J.Manuel.; Núñez-Enríquez, J.Carlos.; Fajardo-Gutiérrez, A.; Rodríguez-Zepeda, Mía.Del.Carmen.; Martín-Trejo, J.Alfonso.; Duarte-Rodríguez, D.Aldebarán.; Medina-Sansón, A.; Flores-Lujano, J.; Jiménez-Hernández, E.; Núñez-Villegas, N.Nancy.; Pérez-Saldívar, Mía.Luisa.; Paredes-Aguilera, R.; Cárdenas-Cardós, Río.; Flores-Chapa, Jé.de.Diego.; Reyes-Zepeda, N.Carolina.; Flores-Villegas, L.Victoria.; Amador-Sánchez, R.; Torres-Nava, Jé.Refugio.; Bolea-Murga, V.; Espinosa-Elizondo, R.Martha.; Peñaloza-González, Jé.Gabriel.; Velázquez-Aviña, M.Margarita.; González-Bonilla, César.; Békker-Méndez, V.Carolina.; Jiménez- 2016: Descriptive epidemiology of children with acute myeloid leukemia residing in Mexico City: a report from the Mexican Inter-Institutional Group for Identifying Childhood Leukemia Causes Gaceta Medica de Mexico 152(Suppl. 2): 66-77
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Chung, C.T.; Chiou, T.J.; Liu, S.M.; Chen, P.M. 1993: Early extramedullary relapse of acute myelogenous leukemia in bilateral breasts: a case report Zhonghua Yi Xue Za Zhi 52(2): 125-127